Leaflet DERMAZIN 1% cream


Indicated for: bacterial infections

Route of administration: cutaneous

Substance: sulfadiazine (antiprotozoal)

ATC: D06BA01 (Dermatologicals | Chemotherapeutics for topical use | Sulfonamides)

Sulfadiazine is a sulfonamide antibiotic used for the treatment of bacterial infections, including urinary tract infections, respiratory infections, and toxoplasmosis. It works by inhibiting folic acid synthesis in bacteria, thereby preventing their growth and multiplication.

The medication is administered orally or intravenously, as directed by a doctor. It is important for patients to complete the full course of treatment to prevent the development of bacterial resistance.

Patients should be aware of potential side effects, such as nausea, skin rashes, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, skin rashes, and diarrhea. In rare cases, severe reactions such as Stevens-Johnson syndrome or kidney dysfunction may occur. Patients should be informed of these risks before starting treatment.

General data about DERMAZIN 1%

  • Substance: sulfadiazine
  • Date of last drug list: 01-07-2013
  • Commercial code: W05705001
  • Concentration: 1%
  • Pharmaceutical form: cream
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: SALUTAS PHARMA GMBH - GERMANIA
  • Holder: LEK PHARMACEUTICALS D.D. - SLOVENIA
  • Number: 11071/2018/02
  • Shelf life: 3 years

Pharmaceutical forms available for sulfadiazine

Concentrations available for sulfadiazine

  • 1%
  • 10mg/g